Detección de la intoxicación por cannabinoides sintéticos en Urgencias: cuando las pruebas toxicológicas rutinarias no bastan

Dal Santo, Francesco; Velasco, Ángela; Fuente-Tomás, Lorena de la; González-Blanco, Leticia; Rodríguez-Revuelta, Julia.
Adicciones (Palma de Mallorca) ; 31(2): 174-176, 2019.
Artículo en Español | IBECS (España) | ID: ibc-185205

Documentos relacionados

  1. Detection of synthetic cannabinoid intoxication in the Emergency Department: when routine toxicological tests are not enough.
  2. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
  3. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice.
  4. Cannabinoid<sub>1</sub> (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose.
  5. Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP.
  6. Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates.
  7. Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on &#916;(9)-tetrahydrocannabinol challenge tests.
  8. Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators.
  9. Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists.
  10. Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837.